News

Palantir Has a Hand in NIH’s Most Ambitious Health Initiative

By Julia Métraux, Mother Jones [cites CGS' Katie Hasson] | 07.07.2026

During his 2015 State of the Union address, then-President Barack Obama announced what he promised would be an ambitious public health project. “Tonight, I’m launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes...

U.S. Federal

The Measured Listener

By Daniel Shanahan, Los Angeles Review of Books | 05.31.2026

This is the 15th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. You can read the first part here. The series...

U.S. States

These companies help parents try to pick their babies' traits. Experts are wary

By Rob Stein, NPR [cites CGS' Katie Hasson] | 05.06.2026

Justin Schleede reaches onto a black lab bench to pick up a tray of small plastic tubes.

"These are saliva...

Genetic Selection

The start-ups dreaming of creating genetically modified babies

By Alexandre Piquard, Le Monde [cites CGS' Katie Hasson] | 05.22.2026

"If proven to be safe, we believe preventive gene editing could be one of the most important health technologies of...

U.S. Federal

Open Letter from Suzanne Parisian

By Suzanne Parisian | 01.31.2005

Suzanne Parisian, M.D

Medical Device Assistance, Inc.
Medical & Regulatory Consulting
7117 North 3rd Street
Phoenix, Arizona 85020
Telephone: (602)...

Stem Cells

Watchdog wants stem cell leaders at first meeting

By Carl T. Hall, San Francisco Chronicle | 01.29.2005
State Sen. Deborah Ortiz, D-Sacramento, said Friday that she intended to call leaders of the Proposition 71 stem cell program...
Stem Cells

Opinion: Prop. 71: Boon or boondoggle?

By admin Los Angeles Daily Breeze | 01.28.2005
One of the most foolish things California has done recently was passing Proposition 71, a $3 billion bond issue for...
Biotech & Pharma

Animal-Human Hybrids Spark Controversy

By Maryann Mott, National Geographic News | 01.25.2005
Scientists have begun blurring the line between human and animal by producing chimeras_a hybrid creature that's part human, part animal....
Bioethics

Stem cell institute, under scrutiny, seeks a leader

By Timothy Roberts, San Jose Business Journal | 01.23.2005
When the committee looking for a president of the California Institute for Regenerative Medicine -- the organization overseeing the state's...
Stem Cells

Stem cell holdings criticized

By Laura Mecoy, Sacramento Bee | 01.21.2005
Ten of the 29 directors of California's new stem cell program serve on biotech or pharmaceutical firms' boards of directors...
Biotech & Pharma

Opinion: Rich Guys With Causes Lack Accountability

By David Wessel, Wall Street Journal | 01.20.2005
The story of the rich man who goes into politics and spends his money to get elected is old and...
Biopolitics

Stem cell panelists show holdings: Economic reports leave some observers uneasy

By Lisa M. Krieger and Paul Jacobs , San Jose Mercury News | 01.19.2005
Robert Klein of Portola Valley, the financier who runs the state's new stem cell research institute, reported that his company...
Biotech & Pharma